Development of a Rapidly-acting Preventative Therapy for Influenza

Awarded Award Notice Posted

Solicitation number
HR001118S0037
Agency
Defense Advanced Research Projects Agency Department of Defense
Awarded
to Dnarx LLC
Set-aside
No set-aside

Opportunity facts

Contract number
HR001119C0060 Federal contract award
NAICS code
541714 Research and Development in Biotechnology (except Nanobiotechnology)
PSC
Not on record

Notice details come from SAM.gov. Updated .

Notice text

This is an award annoucement only under the PReemptive Expression of Protective Alleles and Response Elements (PREPARE) BAA. The BAA is closed.. Awarded Vendors: DNARX LLC. Contract Award Dollar Amount: $3,598,132 Base and $7,115,237 NTE Options. Contract Award Date: 2019-04-09.

Notice history

Notices posted for this opportunity, newest first
Notice Type Posted
Development of a Rapidly-acting Preventative Therapy for Influenza This notice · Award Award Notice
PReemptive Expression of Protective Alleles and Response Elements (PREPARE) Latest pre-solicitation Pre-Solicitation

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity